Cargando…
Role of sodium-glucose co-transporter-2 inhibitors in the management of heart failure in patients with diabetes mellitus
Heart failure (HF) is a major complication of diabetes mellitus (DM). Patients with DM have considerably higher risk for HF than non-diabetic subjects and HF is also more severe in the former. Given the rising prevalence of DM, the management of HF in diabetic patients has become the focus of increa...
Autores principales: | Alkagiet, Stelina, Tziomalos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243487/ https://www.ncbi.nlm.nih.gov/pubmed/32477451 http://dx.doi.org/10.4239/wjd.v11.i5.150 |
Ejemplares similares
-
New guidelines for the diagnosis and management of pulmonary embolism: Key changes
por: Erythropoulou-Kaltsidou, Anastasia, et al.
Publicado: (2020) -
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
por: Kontana, Anastasia, et al.
Publicado: (2019) -
Associations between nonalcoholic fatty liver disease and ischemic stroke
por: Alkagiet, Stelina, et al.
Publicado: (2018) -
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk
por: Erythropoulou-Kaltsidou, Anastasia, et al.
Publicado: (2019) -
Eligibility of sodium–glucose co‐transporter‐2 inhibitors among patients with diabetes mellitus admitted for heart failure
por: Sharma, Abhinav, et al.
Publicado: (2019)